S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RPRX Royalty Pharma PLC

29.4906

3.29 (12.56%)

Jan 10 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Royalty Pharma Charts.

Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Royalty Pharma Charts.

Royalty Pharma PLC News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 10 January 2025 (10 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (10 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (20 hours ago) • Edgar (US Regulatory)

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
Friday 10 January 2025 (20 hours ago) • GlobeNewswire Inc.

Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
Friday 10 January 2025 (21 hours ago) • GlobeNewswire Inc.

Royalty Pharma Announces Dividend Increase
Thursday 9 January 2025 (1 day ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 31 December 2024 (1 week ago) • Edgar (US Regulatory)

Royalty Pharma to Present at Upcoming Investor Conferences
Wednesday 27 November 2024 (1 month ago) • GlobeNewswire Inc.

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

More Royalty Pharma PLC News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions